Carl Snyderman
Otolaryngology · Pittsburgh, PANPI 1104891258
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Spiway, LLC at 45.6% of the total. Reporting peaked in 2024 at $2,997 and has fallen 91.7% since, to $250 in 2025.
Across 26 payments — averaging $235.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spiway, LLC$3K
- Stryker$2K
- KARL Storz Endoscopy-america$1K
- Integra Lifesciences Corporation$239
- Medtronic$167
Across 1 payment — averaging $14,987 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer Healthcare LLC$15K
Across 2 payments — averaging $2597.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Spiway, LLC$5K
What the payments were for
- Consulting fees$2,79446%
- Travel & lodging$2,06234%
- Food & beverage$1,27521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spiway, LLC | 1 | $2,794 |
| Stryker | 17 | $1,919 |
| KARL Storz Endoscopy-america | 4 | $1,012 |
| Integra Lifesciences Corporation | 3 | $239 |
| Medtronic | 1 | $167 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPIWay$2,794
- SCOPIS ENT$782
- CORE$583
- VENTRICULOSCOPE LOTTA$580
- BIPOLAR FORCEPS INSERT, STERILE, 2/PKG$414
- PROPEL$167
- NSE - NEW PRODUCT DEVELOPMENT$117
- Acclarent Aera$106
- XPRESS ENT DILATION SYSTEM$100
How this compares
$6,131 in reported general payments places this provider in the 85th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 112 | $846 |
| Ipratropium Bromide | 26 | $760 |
| Azelastine Hcl | 20 | $333 |
| Chlorhexidine Gluconate | 25 | $118 |
| Doxycycline Hyclate | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Pittsburgh
- Stella LeePittsburgh$438K
- Matthew SpectorPittsburgh$56K
- Umamaheswar DuvvuriPittsburgh$48K
- Jose ZevallosPittsburgh$40K
- Thomas KaffenbergerPittsburgh$33K
- Priya KrishnaPittsburgh$20K
- Eric WangPittsburgh$15K
- Suman GollaPittsburgh$13K
- Giuseppe StaltariPittsburgh$8K
- Warren SwegalPittsburgh$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.